Vertebral metastatic chemodectoma: imaging and therapeutic octreotide. Case report.
The authors report on the use of external-beam radiotherapy and octreotide in a 32-year-old woman who presented with spinal cord compression secondary to metastatic chemodectoma. Scintigraphy studies were used to confirm the presence of somatostatin receptors. Magnetic resonance imaging, and in particular spinal angiography, were performed to define the extent of spinal metastatic disease. The literature on current investigation and management of vertebral metastatic chemodectoma is reviewed.
U-King-Im
Jean Marie
JM
Department of Neurosurgery, Hull Royal Infirmary, United Kingdom. ukingim@hotmail.com
Carroll
Thomas A
TA
Morris
Kevin
K
D000328:Adult; D000792:Angiography; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D015282:Octreotide / Q000627:therapeutic use*; D010236:Paraganglioma, Extra-Adrenal / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary*; D011877:Radionuclide Imaging; D013125:Spinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary*; D013131:Spine / Q000098:blood supply
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide